Answer
The product information advises stopping breastfeeding during treatment because transfer into human milk and risk to the child are unknown.
Sources for this answer
- LIVTENCITY 200 mg film coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- NHS Specialist Pharmacy ServiceNHS Specialist Pharmacy Service · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.